242 related articles for article (PubMed ID: 24431212)
21. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
22. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
[TBL] [Abstract][Full Text] [Related]
23. Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer.
Zhong X; Zheng L; Shen J; Zhang D; Xiong M; Zhang Y; He X; Tanyi JL; Yang F; Montone KT; Chen X; Xu C; Xiang AP; Huang Q; Xu X; Zhang L
Mol Cell Biol; 2016 Nov; 36(21):2742-2754. PubMed ID: 27550813
[TBL] [Abstract][Full Text] [Related]
24. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
Benbrahim-Tallaa L; Webber MM; Waalkes MP
Environ Health Perspect; 2005 Sep; 113(9):1134-9. PubMed ID: 16140617
[TBL] [Abstract][Full Text] [Related]
25. Neoplastic transformation of human small airway epithelial cells induced by arsenic.
Wen G; Calaf GM; Partridge MA; Echiburú-Chau C; Zhao Y; Huang S; Chai Y; Li B; Hu B; Hei TK
Mol Med; 2008; 14(1-2):2-10. PubMed ID: 18037969
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
[TBL] [Abstract][Full Text] [Related]
27. MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects.
Martínez-Pacheco M; Hidalgo-Miranda A; Romero-Córdoba S; Valverde M; Rojas E
Gene; 2014 Jan; 533(2):508-14. PubMed ID: 24080485
[TBL] [Abstract][Full Text] [Related]
28. Transplacental arsenic exposure produced 5-methylcytosine methylation changes and aberrant microRNA expressions in livers of male fetal mice.
Liu J; Gunewardena S; Yue Cui J; Klaassen CD; Chorley BN; Corton JC
Toxicology; 2020 Apr; 435():152409. PubMed ID: 32068019
[TBL] [Abstract][Full Text] [Related]
29. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
[TBL] [Abstract][Full Text] [Related]
30. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
[TBL] [Abstract][Full Text] [Related]
31. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
32. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
Wang XF; Shi ZM; Wang XR; Cao L; Wang YY; Zhang JX; Yin Y; Luo H; Kang CS; Liu N; Jiang T; You YP
J Cancer Res Clin Oncol; 2012 Apr; 138(4):573-84. PubMed ID: 22207524
[TBL] [Abstract][Full Text] [Related]
33. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells.
Wang X; Zhao J; Huang J; Tang H; Yu S; Chen Y
Biochem Biophys Res Commun; 2012 Aug; 425(1):51-7. PubMed ID: 22820191
[TBL] [Abstract][Full Text] [Related]
34. Human bronchial epithelial BEAS-2B cells, an appropriate in vitro model to study heavy metals induced carcinogenesis.
Park YH; Kim D; Dai J; Zhang Z
Toxicol Appl Pharmacol; 2015 Sep; 287(3):240-5. PubMed ID: 26091798
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-21 activation of ERK signaling via PTEN is involved in arsenite-induced autophagy in human hepatic L-02 cells.
Liu X; Luo F; Ling M; Lu L; Shi L; Lu X; Xu H; Chen C; Yang Q; Xue J; Li J; Zhang A; Liu Q
Toxicol Lett; 2016 Jun; 252():1-10. PubMed ID: 27107786
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.
Zhao Y; Pang D; Wang C; Zhong S; Wang S
Tumour Biol; 2016 Aug; 37(8):11485-93. PubMed ID: 27012554
[TBL] [Abstract][Full Text] [Related]
37. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
Kang K; Zhang J; Zhang X; Chen Z
Oncol Rep; 2018 Jan; 39(1):401-410. PubMed ID: 29115540
[TBL] [Abstract][Full Text] [Related]
40. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
Mullany LK; Fan HY; Liu Z; White LD; Marshall A; Gunaratne P; Anderson ML; Creighton CJ; Xin L; Deavers M; Wong KK; Richards JS
Oncogene; 2011 Aug; 30(32):3522-36. PubMed ID: 21423204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]